Article
New CEPS Framework Agreement 2026: Key Takeaways
Industry and institutional representatives gathered in Paris to examine France's new CEPS framework agreement signed in September 2026, analyzing its impact on pharmaceutical pricing, commercial exclusivity, and mature medicines support. The discussion addressed how the agreement balances innovation incentives with patient access and healthcare cost management in the French market.
McDermott Will & Schulte
